Shanghai Fosun Pharmaceutical climbs on vaccine unit's Hong Kong listing plan

FOSUN INTERNATIONAL

23/01/2026 05:54

** Shanghai Fosun Pharmaceutical's Hong Kong shares 2196.HK climb 3.1% to HK$20.86, set for biggest one-day pct gain since Jan 13

** Shanghai-listed stock 600196.SS adds 1.7% to 27.72 yuan, biggest one-day pct rise since Jan 5

** Healthcare group's board of directors approves proposed spin-off and listing of vaccine unit Fosun Adgenvax (Chengdu) Biopharmaceutical in Hong Kong

** Spin-off and listing subject to shareholder, China Securities Regulatory Commission, the Stock Exchange and other authorities approvals - co

** YTD, Hong Kong stock up 5.2%, Shanghai-listed shares up 3.9%

(Reporting by Donny Kwok)

((donny.kwok@thomsonreuters.com))